Cardiac Ablation Market Share

  • Report ID: 4773
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Cardiac Ablation Market Share

North American Market Forecast

The North American cardiac ablation market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2037, backed by the presence of key pharmaceutical equipment companies, along with rise in number of clinical trials. Moreover, the prevalence of heart disease is also high in this region which is also estimated to boost the growth of the cardiac ablation market in this region.  Most prevalent form of heart disease, coronary heart disease (CHD), claims the lives of over 382,820 people each year in United States. Almost 805,000 people experience a heart attack each year. 605,000 of these result in a first-time heart attack, while 200,000 are caused by previous heart attacks. Further, there has been growing investment made in the development of cardiac ablators and rise in technological advancement, which would further enhance productivity which would also boost the cardiac ablation market growth in this region.

APAC Market Statistics

The Asia Pacific cardiac ablation market, amongst the market in all the other regions, is projected to grow with the highest CAGR during the forecast period. The growth of the market in this region can be attributed to the growing geriatric population who are prone to cardiovascular disease. However, adults as well as young people in this region are estimated to diagnose with cardiovascular disease. Although, it has less than 20% of the global population, according to estimates from the Indian Heart Association, India is responsible for over 60% of the burden of heart disease worldwide. This may be attributed to a genetic susceptibility to metabolic dysregulation and cardiomyopathy, as well as a recent change in modifiable risk factors towards increased consumption of red meat, saturated fats, and trans fats, junk foods, and higher levels of stress. Hence, the adoption of cardiovascular disease treatment is estimated to increase in this region, further boosting the market growth. Moreover, there has been a rise in manufacturers of ablation in this region, which is estimated to influence the growth of the cardiac ablation market.

Research Nester
Cardiac Ablation Market Size
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4773
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of cardiac ablation is evaluated at USD 4.28 billion.

The cardiac ablation market size was valued at USD 3.86 billion in 2024 and is likely to exceed USD 20.03 billion by the end of 2037, registering over 13.4% CAGR during the forecast period i.e., between 2025-2037. The market growth is driven by growing prevalence of diabetes mellitus, rising geriatric population, surge in investment in healthcare sector, and others.

North America is anticipated to hold largest industry share by 2037, backed by presence of key pharmaceutical equipment companies, along with rise in number of clinical trials.

The major players in the market include Medtronic, AngioDynamics, Atricure, Inc., Alcon, Boston Scientific Corporation, Olympus Corporation, CONMED Corporation, Medical Device Business Services, Inc., BIOTRONIK SE & Co KG, Biosense Webster, Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample